Medicare
- Blog Post
A Call for New Research in the Area of Spending on Medicare Part D
CBO is looking for new research to help explain the unexpectedly rapid growth of projected per-enrollee costs in bids from Medicare Part D plans.
- Presentation
Effects of the 2022 Reconciliation Act's Drug Provisions: What Have We Learned So Far and What Questions Remain?
Presentation by Austin Barselau, an analyst in CBO's Budget Analysis Division, and Scott Laughery, an analyst in CBO's Health Analysis Division, at a meeting of CBO's Panel of Health Advisers.
- Report
CBO's Estimates of the Statutory Pay-As-You-Go Effects of Public Law 119-21
CBO provides information concerning the effects of a potential sequestration in accordance with the Statutory Pay‑As‑You‑Go Act of 2010 that could occur as a result of the enactment of the 2025 reconciliation act (Public Law 119-21).
- Blog Post
Upcoming Presentations by Staff of CBO’s Health Analysis Division
This summer, analysts in CBO's Health Analysis Division will present their work in three sessions at the 14th Annual Conference of the American Society of Health Economists (ASHEcon) in Nashville, Tennessee.
- Report
Potential Statutory Pay-As-You-Go Effects of a Bill to Provide Reconciliation Pursuant to H. Con. Res. 14, the One Big Beautiful Bill Act
CBO responds to questions concerning the sequestration (cancellation of budgetary resources) that would occur under the Statutory Pay-As-You-Go Act of 2010 if an enacted bill raised deficits by $2.3 trillion over 10 years.
- Presentation
The Federal Perspective on Coverage of Medications to Treat Obesity: Considerations From the Congressional Budget Office
Presentation by Noelia Duchovny, an analyst in CBO’s Health Analysis Division, at the National Institute of Diabetes and Digestive and Kidney Diseases Workshop on GLP-1-Based Therapies.
- Report
The Long-Term Budget Outlook: 2025 to 2055
Extending the 10-year budget projections it published on January 17, 2025, CBO projects that federal debt held by the public, boosted by sustained deficits, will grow far beyond any previously recorded level over the next 30 years.
- Report
The Budget and Economic Outlook: 2025 to 2035
In CBO’s projections, the federal budget deficit is $1.9 trillion this year, and federal debt rises to 118 percent of GDP in 2035. Economic growth slows and inflation declines over the next two years; both remain moderate after 2026.
- Report
How Increased Use of Gene Therapy Treatment for Sickle Cell Disease Could Affect the Federal Budget
Gene therapies replace or modify disease-causing genes in human cells. In this report, CBO discusses how it would estimate the budgetary effects of policies that sought to increase the use of gene therapy treatment for sickle cell disease.
- Cost Estimate
H.R. 7931, Preserving Emergency Access in Key Sites Act
As ordered reported by the House Committee on Ways and Means on May 8, 2024, and June 27, 2024